If the aggression of licensing laws ended, patients and their physicians could buy whichever drugs they felt might be helpful, regardless of the stage of testing. Since they could not competently evaluate every drug for themselves, they would probably rely on a professional or consumer's group for a status report on pharmaceuticals they were considering. Patients and physicians could choose to defer to one of these "authorities," but none could force adherence to their verdict.
Dr. Mary J. Ruwart
No comments:
Post a Comment